NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Red Tree Venture Capital

Red Tree Venture Capital

Redwood City, Californiaredtreevc.com

Overview

Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations . The firm focuses primarily on entrepreneurs developing first-in-class and/or best-in-class therapeutics addressing significant unmet needs in the areas of oncology, neurology, and immunology .

Year Founded

2020

Portfolio Companies

11

Investments

Red Tree Venture Capital investments
CompanyDateStageLead
ExcellergyOct 2025Series ACo-investor
Magnus MedicalMay 2025Series BCo-investor
Kivu BiosciencesOct 2024Series ACo-investor
BioGraph 55Jun 2024Series BCo-investor
Engrail TherapeuticsMar 2024Series BCo-investor

Key People

Cassie Lue

Vice President Of Investor Relations

Jeremy Caldwell

Partner, Red Tree Venture Capital

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRedwood City, California
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.